IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity

Journal of Autoimmunity

Volumn 75, Issue , 2016, Pages 39-49

  Lippens, Carla ^a   Duraes, Fernanda V ^a,c   Dubrot, Juan ^a   Brighouse, Dale ^a   Lacroix, Mathilde ^a   Irla, Magali ^a   Aubry Lachainaye, Jean Pierre ^a   Reith, Walter ^a   Mandl, Judith N ^b   Hugues, Stéphanie ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antigen presentation; Experimental autoimmune encephalomyelitis; Indoleamine 2,3 dyoxygenase; Plasmacytoid dendritic cells; Regulatory T cells; Tolerance

Indexed keywords

CD103 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; KI 67 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPH NODE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; COCULTURE; DENDRITIC CELL; ENZYMOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNITY; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPH NODES; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY;

EID: 84979650031     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.07.004     Document Type: Article

References (61)

1. [1] Cervantes-Barragan, L., Zust, R., Weber, F., Spiegel, M., Lang, K.S., Akira, S., Thiel, V., Ludewig, B., Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109 (2007), 1131–1137.
2. [2] Colonna, M., Trinchieri, G., Liu, Y.J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 (2004), 1219–1226.
3. [3] Chan, V.S., Nie, Y.J., Shen, N., Yan, S., Mok, M.Y., Lau, C.S., Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 11 (2012), 890–897.
4. [4] Kared, H., Masson, A., Adle-Biassette, H., Bach, J.F., Chatenoud, L., Zavala, F., Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54 (2005), 78–84.
5. [5] Longhini, A.L., von Glehn, F., Brandao, C.O., de Paula, R.F., Pradella, F., Moraes, A.S., Farias, A.S., Oliveira, E.C., Quispe-Cabanillas, J.G., Abreu, C.H., et al. Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse. J. Neuroinflammation, 8, 2011, 2.
6. [6] Nestle, F.O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y.J., Gilliet, M., Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202 (2005), 135–143.
7. [7] Reder, A.T., Feng, X., Aberrant type I interferon regulation in autoimmunity: opposite directions in MS and SLE, shaped by evolution and body ecology. Front. Immunol., 4, 2013, 281.
8. [8] Gilliet, M., Cao, W., Liu, Y.J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8 (2008), 594–606.
9. [9] Swiecki, M., Colonna, M., The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15 (2015), 471–485.
10. [10] Villadangos, J.A., Young, L., Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29 (2008), 352–361.
11. [11] Di Pucchio, T., Chatterjee, B., Smed-Sorensen, A., Clayton, S., Palazzo, A., Montes, M., Xue, Y., Mellman, I., Banchereau, J., Connolly, J.E., Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9 (2008), 551–557.
12. [12] Hoeffel, G., Ripoche, A.C., Matheoud, D., Nascimbeni, M., Escriou, N., Lebon, P., Heshmati, F., Guillet, J.G., Gannage, M., Caillat-Zucman, S., et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27 (2007), 481–492.
13. [13] Sapoznikov, A., Fischer, J.A., Zaft, T., Krauthgamer, R., Dzionek, A., Jung, S., Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J. Exp. Med. 204 (2007), 1923–1933.
14. [14] Young, L.J., Wilson, N.S., Schnorrer, P., Proietto, A., ten Broeke, T., Matsuki, Y., Mount, A.M., Belz, G.T., O'Keeffe, M., Ohmura-Hoshino, M., et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9 (2008), 1244–1252.
15. [15] Guery, L., Hugues, S., Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity. Front. Immunol., 4, 2013, 59.
16. [16] Goubier, A., Dubois, B., Gheit, H., Joubert, G., Villard-Truc, F., Asselin-Paturel, C., Trinchieri, G., Kaiserlian, D., Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29 (2008), 464–475.
17. [17] Liu, X., Mishra, P., Yu, S., Beckmann, J., Wendland, M., Kocks, J., Seth, S., Hoffmann, K., Hoffmann, M., Kremmer, E., et al. Tolerance induction towards cardiac allografts under costimulation blockade is impaired in CCR7-deficient animals but can be restored by adoptive transfer of syngeneic plasmacytoid dendritic cells. Eur. J. Immunol. 41 (2011), 611–623.
18. [18] Ochando, J.C., Homma, C., Yang, Y., Hidalgo, A., Garin, A., Tacke, F., Angeli, V., Li, Y., Boros, P., Ding, Y., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7 (2006), 652–662.
19. [19] Guery, L., Dubrot, J., Lippens, C., Brighouse, D., Malinge, P., Irla, M., Pot, C., Reith, W., Waldburger, J.M., Hugues, S., Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression. Cancer Res. 74 (2014), 6430–6440.
20. [20] Sage, A.P., Murphy, D., Maffia, P., Masters, L.M., Sabir, S.R., Baker, L.L., Cambrook, H., Finigan, A.J., Ait-Oufella, H., Grassia, G., et al. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity. Circulation 130 (2014), 1363–1373.
21. [21] Loschko, J., Schlitzer, A., Dudziak, D., Drexler, I., Sandholzer, N., Bourquin, C., Reindl, W., Krug, A.B., Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity. J. Immunol. 186 (2011), 6718–6725.
22. [22] Loschko, J., Heink, S., Hackl, D., Dudziak, D., Reindl, W., Korn, T., Krug, A.B., Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity. J. Immunol. 187 (2011), 6346–6356.
23. [23] Irla, M., Kupfer, N., Suter, T., Lissilaa, R., Benkhoucha, M., Skupsky, J., Lalive, P.H., Fontana, A., Reith, W., Hugues, S., MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207 (2010), 1891–1905.
24. [24] Baban, B., Chandler, P.R., Sharma, M.D., Pihkala, J., Koni, P.A., Munn, D.H., Mellor, A.L., IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J. Immunol. 183 (2009), 2475–2483.
25. [25] Chen, W., Liang, X., Peterson, A.J., Munn, D.H., Blazar, B.R., The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 181 (2008), 5396–5404.
26. [26] Yang, J., Yang, Y., Fan, H., Zou, H., Tolerogenic splenic IDO (+) dendritic cells from the mice treated with induced-Treg cells suppress collagen-induced arthritis. J. Immunol. Res., 2014, 2014, 831054.
27. [27] Fallarino, F., Grohmann, U., Hwang, K.W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M.L., Fioretti, M.C., Alegre, M.L., Puccetti, P., Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4 (2003), 1206–1212.
28. [28] Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M.L., Bianchi, R., Fioretti, M.C., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3 (2002), 1097–1101.
29. [29] Manlapat, A.K., Kahler, D.J., Chandler, P.R., Munn, D.H., Mellor, A.L., Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur. J. Immunol. 37 (2007), 1064–1071.
30. [30] Mellor, A.L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P.A., Iwashima, M., Munn, D.H., Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171 (2003), 1652–1655.
31. [31] Fallarino, F., Asselin-Paturel, C., Vacca, C., Bianchi, R., Gizzi, S., Fioretti, M.C., Trinchieri, G., Grohmann, U., Puccetti, P., Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173 (2004), 3748–3754.
32. [32] Baban, B., Hansen, A.M., Chandler, P.R., Manlapat, A., Bingaman, A., Kahler, D.J., Munn, D.H., Mellor, A.L., A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int. Immunol. 17 (2005), 909–919.
33. [33] Munn, D.H., Sharma, M.D., Mellor, A.L., Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172 (2004), 4100–4110.
34. [34] Sharma, M.D., Hou, D.Y., Liu, Y., Koni, P.A., Metz, R., Chandler, P., Mellor, A.L., He, Y., Munn, D.H., Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113 (2009), 6102–6111.
35. [35] Pallotta, M.T., Orabona, C., Volpi, C., Vacca, C., Belladonna, M.L., Bianchi, R., Servillo, G., Brunacci, C., Calvitti, M., Bicciato, S., et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12 (2011), 870–878.
36. [36] Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., Wagner, H., Huehn, J., Sparwasser, T., Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204 (2007), 57–63.
37. [37] Schaefer, B.C., Schaefer, M.L., Kappler, J.W., Marrack, P., Kedl, R.M., Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell Immunol. 214 (2001), 110–122.
38. [38] Reith, W., LeibundGut-Landmann, S., Waldburger, J.M., Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5 (2005), 793–806.
39. [39] Baban, B., Chandler, P., McCool, D., Marshall, B., Munn, D.H., Mellor, A.L., Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol. 61 (2004), 67–77.
40. [40] Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y., Colonna, M., Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33 (2010), 955–966.
41. [41] Barnden, M.J., Allison, J., Heath, W.R., Carbone, F.R., Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76 (1998), 34–40.
42. [42] Kaye, J., Hsu, M.L., Sauron, M.E., Jameson, S.C., Gascoigne, N.R., Hedrick, S.M., Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341 (1989), 746–749.
43. [43] Oxenius, A., Bachmann, M.F., Zinkernagel, R.M., Hengartner, H., Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28 (1998), 390–400.
44. [44] Means, G.D., Toy, D.Y., Baum, P.R., Derry, J.M., A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation. Genomics 65 (2000), 213–223.
45. [45] Bettelli, E., Pagany, M., Weiner, H.L., Linington, C., Sobel, R.A., Kuchroo, V.K., Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003), 1073–1081.
46. [46] Domingues, H.S., Mues, M., Lassmann, H., Wekerle, H., Krishnamoorthy, G., Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One, 5, 2010, e15531.
47. [47] Fallarino, F., Gizzi, S., Mosci, P., Grohmann, U., Puccetti, P., Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr. Drug Metab. 8 (2007), 209–216.
48. [48] Mandl, J.N., Monteiro, J.P., Vrisekoop, N., Germain, R.N., T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity 38 (2013), 263–274.
49. [49] LeibundGut-Landmann, S., Waldburger, J.M., Krawczyk, M., Otten, L.A., Suter, T., Fontana, A., Acha-Orbea, H., Reith, W., Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34 (2004), 1513–1525.
50. [50] LeibundGut-Landmann, S., Waldburger, J.M., Reis e Sousa, C., Acha-Orbea, H., Reith, W., MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 5 (2004), 899–908.
51. [51] Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., Bechmann, I., Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 19 (2005), 1347–1349.
52. [52] Sakurai, K., Zou, J.P., Tschetter, J.R., Ward, J.M., Shearer, G.M., Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 129 (2002), 186–196.
53. [53] Barthlott, T., Bosch, A.J., Berkemeier, C., Nogales-Cadenas, R., Jeker, L.T., Keller, M.P., Pascual-Montano, A., Hollander, G.A., A subpopulation of CD103(pos) ICOS(pos) Treg cells occurs at high frequency in lymphopenic mice and represents a lymph node specific differentiation stage. Eur. J. Immunol. 45 (2015), 1760–1771.
54. [54] Rowland, S.L., Riggs, J.M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E.R., Sanjuan, M.A., Colonna, M., Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 211 (2014), 1977–1991.
55. [55] Meyer Zu Horste, G., Zozulya, A.L., El-Haddad, H., Lehmann, H.C., Hartung, H.P., Wiendl, H., Kieseier, B.C., Active immunization induces toxicity of diphtheria toxin in diphtheria resistant mice–implications for neuroinflammatory models. J. Immunol. Methods 354 (2010), 80–84.
56. [56] Mellor, A.L., Munn, D.H., IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4 (2004), 762–774.
57. [57] Munn, D.H., Sharma, M.D., Lee, J.R., Jhaver, K.G., Johnson, T.S., Keskin, D.B., Marshall, B., Chandler, P., Antonia, S.J., Burgess, R., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002), 1867–1870.
58. [58] Grant, C.R., Liberal, R., Mieli-Vergani, G., Vergani, D., Longhi, M.S., Regulatory T-cells in autoimmune diseases: challenges, controversies and–yet–unanswered questions. Autoimmun. Rev. 14 (2015), 105–116.
59. [59] Boissonnas, A., Scholer-Dahirel, A., Simon-Blancal, V., Pace, L., Valet, F., Kissenpfennig, A., Sparwasser, T., Malissen, B., Fetler, L., Amigorena, S., Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 32 (2010), 266–278.
60. [60] Coquerelle, C., Oldenhove, G., Acolty, V., Denoeud, J., Vansanten, G., Verdebout, J.M., Mellor, A., Bluestone, J.A., Moser, M., Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis. Gut 58 (2009), 1363–1373.
61. [61] Mellor, A.L., Chandler, P., Baban, B., Hansen, A.M., Marshall, B., Pihkala, J., Waldmann, H., Cobbold, S., Adams, E., Munn, D.H., Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16 (2004), 1391–1401.